FOS – Fructo-oligosaccharides 60 capsules (500mg/capsule)

30.00

The use of Fructo-oligosaccharides known as FOS, as a prebiotic, has shown positive effects on beneficial bacteria. FOS are non-caloric and atypical sugars unmetabolized by the human body, yet fermentable by the colonic microbiota, delivering favorable impacts on mineral and trace element absorption. Enhanced mineral absorption2, particularly calcium, magnesium, and iron, subsequent to FOS intake. Postmenopausal women experienced heightened absorption of minerals and trace elements. Apart from mineral absorption, FOS has also shown positive effects on carbohydrate and lipid metabolism, hormone balance, and nitrogen homeostasis. The prebiotic showcases the potential applications in reducing the risk of various diseases7, including constipation, infectious diarrhoea, cancer, osteoporosis, atherosclerotic cardiovascular disease, obesity, and non-insulin dependent diabetes3. FOS’s positive impact1 on beneficial bacteria like Lactobacillus and Bifidobacterium5, resulting in a reduction in potentially harmful bacteria4, alongside butyrate-producing6 microbes such as Faecalibacterium, Ruminococcus, and Oscillospira, showcase the potential of FOS in promoting the growth of beneficial gut bacteria and enhancing bacterial diversity, conferring valuable advantages to the host’s overall health.

Description

Dosage: 500mg per capsule

Capsules per order: 60 capsules

Instructions: 2 capsules daily (morning & evening)

Citations:

  1. Tandon, D., Haque, M.M., Gote, M. et al. A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora. Sci Rep 9, 5473 (2019). https://doi.org/10.1038/s41598-019-41837-3
  2. G.T. Costa, Q.D.J.S. Vasconcelos, G.C. Abreu, A.O. Albuquerque, J.L. Vilar, G.F. Aragão, Systematic review of the ingestion of fructooligosaccharides on the absorption of minerals and trace elements versus control groups, Clinical Nutrition ESPEN, Volume 41, 2021, Pages 68-76, ISSN 2405-4577. https://doi.org/10.1016/j.clnesp.2020.11.007
  3. Roberfroid MB, Delzenne NM. Dietary fructans. Annu Rev Nutr 1998;18: 117e43. https://pubmed.ncbi.nlm.nih.gov/9706221/
  4. Roberfroid MB. Health benefits of non-digestible oligosaccharides. Adv Exp Med Biol 1997;427:211-9. https://pubmed.ncbi.nlm.nih.gov/9361846/
  5. Gibson GR. Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998;80(4):S209-12. https://pubmed.ncbi.nlm.nih.gov/9924286/
  6. Le Blay G, Michel C, Blottiere HM, Cherbut C. Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in cecal butyrate in rats. J Nutr 1999;129(12):2231-5. https://pubmed.ncbi.nlm.nih.gov/10573555/
  7. Tomomatsu H. Health effects of oligosaccharides. Food Technol 1994;48(10): 61-5. https://www.scirp.org/reference/ReferencesPapers?ReferenceID=106939